Live Breaking News & Updates on Cambridge Allergy Ltd

Stay updated with breaking news from Cambridge allergy ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cambridge Allergy Ltd: Camallergy Awarded £1.1 M Funding Under Innovate UK Biomedical Catalyst Award for Novel Peanut Allergy Treatment


Cambridge Allergy Ltd: Camallergy Awarded £1.1 M Funding Under Innovate UK Biomedical Catalyst Award for Novel Peanut Allergy Treatment
-Company to provide corporate update at upcoming Global Life Sciences investor conference
Cambridge Allergy Ltd ( Camallergy or the Company ), a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced it has been awarded
£1.1M funding under the Innovate UK Biomedical Catalyst Award program administered by Innovate UK, the United Kingdom s research and innovation agency.
The
£1.1M in non-dilutive funding will be used to accelerate the Company s peanut allergy immunotherapy, CA002, for planned Phase 3 clinical trials. The project commences in the first quarter of 2021, and as part of the project s success, the Company intends to file its investigation new drug application with the FDA and submit a clinical trials application to the MHRA a ....

United Kingdom , Kostenloser Wertpapierhandel , Sarah Oakley Mudge , Cambridge Allergy Ltd Camallergy , Global Life Sciences , Hc Wainwright Global Life Sciences Conference , Foundation Trust In Cambridge , Cambridge University Hospitals , Camallergy Cambridge Allergy Ltd , Clinical Development , Allergy Ltd , Innovate United Kingdom Biomedical Catalyst Award , Innovate United Kingdom , Global Life Sciences Conference , Chief Executive Officer , Cambridge Allergy Ltd , Chief Financial Officer , ஒன்றுபட்டது கிஂக்டம் , சாரா ஓக்லி முணுமுணுப்பு , உலகளாவிய வாழ்க்கை அறிவியல் , ஹ்ஸீ வேந்‌ரைட் உலகளாவிய வாழ்க்கை அறிவியல் மாநாடு , அடித்தளம் நம்பிக்கை இல் கேம்பிரிட்ஜ் , கேம்பிரிட்ஜ் பல்கலைக்கழகம் மருத்துவமனைகள் , மருத்துவ வளர்ச்சி , ஒவ்வாமை லிமிடெட் , புதுமை ஒன்றுபட்டது கிஂக்டம் உயிர் மருத்துவ வினையூக்கி விருது ,

Camallergy's UK Based Manufacturing Facility Receives cGMP Licences for Peanut Allergy Treatment


Share:
-Facility to supply drug product for planned Phase 3 clinical trials and early access programme
Cambridge Allergy Ltd ( Camallergy or the Company ), a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced that its manufacturing facility outside of Portsmouth, United Kingdom was approved by the MHRA, the Medicines and Healthcare products Regulatory Agency, to manufacture its proprietary peanut allergy treatment under current Good Manufacturing Practices (cGMP) standards.
This clearance is a pivotal regulatory milestone that further supports Camallergy s leadership and capabilities in the field of peanut allergy immunotherapy with the only cGMP-certified manufacturing facility in Europe producing peanut oral immunotherapy, said Sherden Timmins, Chief Technology Officer. ....

United Kingdom , Sherden Timmins , Baxter Phillips , Cambridge Allergy Ltd Camallergy , Technology Officer , Foundation Trust In Cambridge , Cambridge University Hospitals , Camallergy Cambridge Allergy Ltd , Regulatory Agency , Only European , Allergy Ltd , Good Manufacturing Practices , Chief Technology , Investigational New Drug , Investigational Medicinal Product Dossier , Cambridge Allergy Ltd , ஒன்றுபட்டது கிஂக்டம் , ஷெர்டன் டைமின்கள் , பாக்ஸ்டர் பிலிப்ஸ் , தொழில்நுட்பம் அதிகாரி , அடித்தளம் நம்பிக்கை இல் கேம்பிரிட்ஜ் , கேம்பிரிட்ஜ் பல்கலைக்கழகம் மருத்துவமனைகள் , மட்டும் ஐரோப்பிய , ஒவ்வாமை லிமிடெட் , நல்ல உற்பத்தி ப்ர்யாக்டிஸஸ் , தலைமை தொழில்நுட்பம் ,